INS and Hypoglycemia: More severe, though less common, adverse reactions include risk of C-cell tumors, acute pancreatitis, cholelithiasis, hypoglycemia (especially while combined with insulin), elevated heart rate, renal impairment, hypersensitivity reactions, suicidal ideation, and behavior.